Orsted plunges 27% as it plans $9.4 billion rights issue after ‘adverse’ turn in U.S. market

Orsted plunges 27% as it plans .4 billion rights issue after ‘adverse’ turn in U.S. market


Burbo Bank, Liverpool Bay, England, viewed from the sea turbines on Burbo wind farm off the U.K. coast.

Ucg | Universal Images Group | Getty Images

Orsted shares crashed more than 25% on Monday morning, after the wind farm developer said it plans a 60 billion Danish kroner ($9.4 billion) rights issue, following a “material adverse development” in the U.S. market.

The company said this turn of events left it unable to raise funds from a planned partial divestment of its Sunrise Wind project off the coast of New York.

Given the market conditions, Orsted’s board of directors decided to end the process of selling a stake in Sunrise Wind, which would have provided the “required strengthening” of its capital structure to support its investment and business development programs.

Orsted — the world’s largest offshore wind developer — will be offering existing shareholders first refusal on the new shares under the planned move, which is being backed by the Danish State, the company’s largest shareholder.

Shares were 26.8% lower by 9:09 a.m. in London (4:09 a.m. ET).

This breaking news story is being updated.



Source

Rare earths stocks surge after China tightens grip on global supplies
World

Rare earths stocks surge after China tightens grip on global supplies

A wheel loader operator fills a truck with ore at the MP Materials rare earth mine in Mountain Pass, California, U.S. January 30, 2020. Steve Marcus | Reuters Shares of U.S. rare earth and critical mineral miners surged Thursday after China tightened restrictions on exports, fuelling market speculation that the Trump administration will move more […]

Read More
Novo Nordisk shares slip after pharma giant announces .7 billion U.S. acquisition
World

Novo Nordisk shares slip after pharma giant announces $4.7 billion U.S. acquisition

LONDON — Shares of Danish pharmaceutical giant Novo Nordisk fell 1.1% on Thursday after the company announced plans to acquire U.S. biotech firm Akero Therapeutics. The deal will see Novo pay $54 per share, valuing Akero at $4.7 billion, with the acquisition also including a contingent value right of $6 per share, potentially adding another […]

Read More
U.S. opens probe into nearly 2.9 million Tesla vehicles over FSD traffic violations
World

U.S. opens probe into nearly 2.9 million Tesla vehicles over FSD traffic violations

A Tesla Model 3 using autopilot FSD is shown giving a warning on the screen to pay attention while driving on the highway in Palm Springs, California, U.S., Oct. 12, 2024.  Mike Blake | Reuters The U.S. National Highway Traffic Safety Administration said on Thursday that it is opening an investigation into 2.88 million Tesla […]

Read More